Home Mf Research Tata India Pharma Healthcare Fund Regular Plan Growth

Tata India Pharma & Healthcare Fund - Regular Plan - Growth

-
-
  • 1W
  • 2W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • SI
Fund info
NAV (as on 2025-07-18)
30.77 -0.61%
AUM (Fund Size)
40
Expense Ratio
2.17%
Exit load
0.25% of NAV if redeemed /switched out before 30 days from the date of allotment.
Risk
Very High
AMC
Tata Mutual Fund
View AMC Details

SIP Returns

Period Invested for ₹1000 SIP Started on Investments Latest Value Abs. Returns
One Week 2025-07-11 ₹1,000.00 ₹1,014.35
1.43 %
Two Week 2025-07-03 ₹1,000.00 ₹1,010.28
1.03 %
One Month 2025-06-18 ₹1,000.00 ₹1,042.24
4.22 %
Three Months 2025-04-21 ₹3,000.00 ₹3,138.64
4.62 %
Six Months 2025-01-20 ₹6,000.00 ₹6,339.34
5.66 %
One Year 2024-07-18 ₹12,000.00 ₹12,527.64
4.40 %
Three Year 2022-07-19 ₹36,000.00 ₹51,521.14
43.11 %
Five Year 2020-07-20 ₹60,000.00 ₹99,065.32
65.11 %
Since Inception 2015-12-28 ₹117,000.00 ₹289,428.39
147.37 %

Return Calculator

SIP Amount
1M
6M
1Y
3Y
5Y
Investment
₹0
Maturity Value
₹0
Abs. Returns
0
Current CAGR
0

Portfolio

Allocation of Equity and Debt Asset Classes.

Equity 69%
Debt N/A
Others 0%

Sectors Holding in Tata India Pharma & Healthcare Fund - Regular Plan - Growth

Pharmaceuticals & Biotechnology
46%
Healthcare Services
21%
Insurance
1%
Fertilizers & Agrochemicals
1%
Retailing
0%
IT - Services
0%
Chemicals & Petrochemicals
0%
Healthcare Equipment & Supplies
0%
Other
8%

Companies Holding in Tata India Pharma & Healthcare Fund - Regular Plan - Growth

SUN PHARMACEUTICAL INDUSTRIES LTD
11.64%
APOLLO HOSPITALS ENTERPRISE LTD
6.22%
CIPLA LTD
5.83%
AUROBINDO PHARMA LTD
5.73%
DIVI LABORATORIES LTD
5.63%
FORTIS HEALTHCARE LTD
4.90%
LUPIN LTD
4.82%
ASTER DM HEALTHCARE LTD
4.35%
WOCKHARDT LTD
3.27%
DR REDDYS LABORATORIES LTD
3.16%
ALKEM LABORATORIES LTD
3.11%
HEALTHCARE GLOBAL ENTERPRISES LTD
2.93%
AJANTA PHARMA LTD
1.93%
METROPOLIS HEALTHCARE LTD
1.86%
TORRENT PHARMACEUTICALS LTD
1.83%
KRISHNA INSTITUTE OF MEDICAL SCIENCES LTD
1.82%
MEDI ASSIST HEALTHCARE SERVICES LTD
1.68%
FDC LTD
1.68%
DR. LAL PATH LABS LTD
1.66%
IPCA LABORATORIES LTD
1.65%
INDOCO REMEDIES LTD
1.36%
JUPITER LIFE LINE HOSPITALS LTD
1.27%
DR. AGARWALS HEALTH CARE LTD
1.25%
AKUMS DRUGS AND PHARMACEUTICALS LTD
1.19%
COROMANDEL INTERNATIONAL LTD
1.12%
ZYDUS LIFESCIENCES LTD
1.04%
SANOFI INDIA LTD
0.96%
AMI ORGANICS LTD
0.96%
MEDPLUS HEALTH SERVICES LTD
0.93%
MANKIND PHARMA LTD
0.83%
SANOFI CONSUMER HEALTHCARE INDIA LTD
0.82%
PROCTER & GAMBLE HEALTH LTD
0.75%
GLAXOSMITHKLINE PHARMACEUTICALS LTD
0.66%
ORCHID PHARMA LTD
0.59%
SYNGENE INTERNATIONAL LTD
0.56%
INVENTURUS KNOWLEDGE SOLUTIONS LTD
0.51%
DEEPAK NITRITE LTD
0.29%
LAXMI DENTAL LTD
0.04%
A) REPO
0.24%
CASH / NET CURRENT ASSET
8.93%

Risk Ratios

Std. Deviation N/A
Beta N/A
Sharpe Ratio N/A
Lock In Period N/A
Residual Maturity N/A

Standard Deviation:

Standard deviation numbers measure the variability or volatility of a fund's returns over a specific time period (often 3 years).
  • Low standard deviation = Stable, predictable returns → Suitable for conservative investors seeking stability.
  • High standard deviation = High volatility, more risk → Be cautious, suitable for risk-tolerant investors who can handle fluctuations.

Beta:

Beta measures a fund's volatility about the market or a benchmark. A lower beta means the fund's performance is less sensitive to market movements, making it more predictable compared to the market.
  • Low beta = Less sensitive to market changes → Great for investors with less market exposure.
  • High beta = More sensitive to market changes → Better for aggressive investors who seek higher returns but can handle market risks.

Sharpe Ratio:

The Sharpe Ratio measures how much return a fund has made compared to the risk it carries. A higher Sharpe ratio indicates better returns relative to the risk taken, meaning the fund delivers more efficiently.
  • A higher Sharpe ratio indicates better risk-adjusted returns → Look for funds with higher ratios for better return efficiency.
  • Use it to compare different funds' efficiency in generating returns relative to the risk taken.

Lock-In Period:

India's "lock-in period" in mutual funds encourages long-term investment, particularly in tax-saving schemes preventing redemption or selling of units.

Lock-in times for various investment types

  • Most ELSS mutual fund holders hold for 3 years.
  • Tax savings FDs lock in for 5 years.
  • The lock-in period for 8% Government of India bond investment is 6 years.
  • ULIPs must be locked in for 5 years.
  • The average hedge fund holding period is 30-90 days.
  • The average PPF investor holds onto their money for 15 years.

Residual Maturity:

Residual maturity is the remaining time until a security reaches its maturity date. It is an important factor for investors to consider when evaluating the risk associated with an investment.

There are two different types of residual maturity.

  • Short-term residual maturity: This occurs when a security has less than a year left on its maturity.
  • Long-term residual maturity: This occurs when a security has more than a year left on its remaining maturity.

Risk-O-Meter

Investors understand that their principal will be at
Very High

Scheme Details

Min. SIP Amount
N/A
Min. Lumpsum Amount
N/A
AUM (in Cr.)
N/A
Expense Ratio Regular
2.17
Expense Ratio Direct
0.72
Lock-in Period
N/A
Fund Age
N/A
Benchmark
N/A
Fund managers
Meeta Shetty
17 years Experience

Exit load

0.25% of NAV if redeemed /switched out before 30 days from the date of allotment.

FAQs

Is a Mutual Fund with a Lower NAV Better?
What Are the Charges in Mutual Fund Investments?
What Are the Tax Benefits of Mutual Funds?
Is It a Good Time to Invest in Mutual Funds?
What Is the Difference Between Dividend and Growth Plans?
Should I Invest in Infrastructure Funds?
What Are Sector-Specific Funds/Schemes?
What Happens If I Miss an SIP Payment?
How Can I Compare Different Mutual Funds?